FBLG fibrobiologics.com: Earnings growth forecast for next year

Corporate company logo of FibroBiologics (FBLG)

The prospects for FibroBiologics, Inc. (FBLG) depend on the outcomes of clinical trials for multiple sclerosis treatment and M&A deals. The expected EPS change for the coming year confirms these expectations, where 0.00 determines this parameter level. Patents for the mass production of cellular products drive margin growth, although expansion is constrained by high R&D costs and intellectual property maintenance.

FibroBiologics Corp (FBLG): Expected earnings per share trend next year from 02/21/2024 to 11/15/2026

Comprehensive metric breakdowns and analytics for FibroBiologics Inc. (FBLG)

- share price and consensus valuation forecast:
Stock Price FibroBiologics|FBLG - Analyst Median Target
- company stock capitalization data:
Market Capitalization FibroBiologics Inc.|FBLG - Total Company Value
- book capitalization indicators:
Net Assets per Single Share FibroBiologics|FBLG - Accounting Value of Company|Market Value to Book Value Ratio fibrobiologics.com|FBLG - Company Assets
- debt and solvency information:
Total Debt to Capital FibroBiologics, Inc.|FBLG - Long-Term Debt to Equity|Short-Term Debt to Capital FibroBiologics|FBLG - Company Total Debt Obligations|Debt to Book Capitalization Ratio FibroBiologics|FBLG - Long-Term Debt|Company Short-Term Debt FibroBiologics|Quick Liquidity fibrobiologics.com
- net income and valuation ratios data:
FBLG - Company Net Income|Projected Future Earnings FibroBiologics, Inc.|FBLG - Market Cap to Net Income Ratio|Forward P/E Multiple FibroBiologics|FBLG - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple FibroBiologics Corp|FBLG - Operating profit before deduction of amortization|Earnings per share for the last twelve months FibroBiologics|FBLG - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months fibrobiologics.com|FBLG - Earnings per share increase in current year|Earnings growth forecast for next year FibroBiologics, Inc.
- sales and revenue indicators:
FBLG - Company Gross Revenue|Company Projected Revenue FibroBiologics|FBLG - Market Cap to Revenue Ratio|Forward P/S Multiple FibroBiologics Corp|FBLG - Revenue Growth YoY (Last 12 Months)
Initial company analysis:FBLG, FibroBiologics, Inc.
Finished products of FibroBiologics

The cell therapy development outsourcing model of FibroBiologics, Inc. (FBLG) makes its financial performance dependent on the efficiency of external contractors. This indicator measures the expected year-over-year change in earnings per share, reflecting the analysts' consensus forecast regarding the future profitability of the business. Monitoring the 12-month EPS growth targets allows investors to assess the sustainability of the company's capitalization amid tight monetary policy.

Competitors of FibroBiologics, Inc.

MESO (Mesoblast Ltd) - Earnings growth forecast for next year|lineagecell.com (LCTX) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Surrozen (SRZN)|CCEL - Expected net earnings per share growth next year|Earnings growth forecast for next year LGVN (Longeveron Inc)|Expected earnings per share trend next year BRTX|CELZ: Expected earnings per share growth for next year